In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company in the world.

Fintel reports that on October 17, 2024, Bernstein initiated coverage of Eli Lilly and (NYSE:LLY) with a Outperform ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

Prothena Corporation plc's stock has dropped 67% since my last “Buy” rating, primarily due to delays and a lack of meaningful ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where Eli ...

New data released by Merck suggests AstraZeneca and Sanofi’s Beyfortus, the monoclonal antibody injection that protects ...

U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Non-Cum. Perp. Pfd. Series K) 0.16% U.S. Bancorp Dep. Pfd. (Rep. 1/1000th Perp. 3.75% Pfd. Series L) 0.16% U.S. Bancorp Dep. Pfd ...

2-Year U.S. Treasury Note Continuous Contract $103.398 0.012 0.01% 5-Year U.S. Treasury Note Continuous Contract $108.336 0.000 0.00% 10-Year U.S. Treasury Note Continuous Contract $112.016-0.031 ...

From the end of November Market data will no longer be displayed here.